SCHEMBL19623707

SCHEMBL19623707

C1=CCN(Cc2cccc(-c3nc(N4CCCCC4)nc4c3CCC4)c2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 3/20 0.40
CASP5 P51878 3/20 0.40
KMT2A Q03164 1/20 0.40
CASP4 P49662 2/20 0.40
LMNA P02545 3/20 0.39
HTT P42858 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
DRD2 P14416 3/20 0.38
DRD4 P21917 3/20 0.38
DRD3 P35462 3/20 0.38
IGF1R P08069 4/20 0.38
HPGD P15428 1/20 0.38
ACP1 P24666 1/20 0.37
KDM5B Q9UGL1 1/20 0.36
APP P05067 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24697805 0.91 CASP1 (0.44) CASP1CASP5KMT2ACASP4LMNA
SCHEMBL24699446 0.90 CASP1 (0.45) CASP1CASP5CASP4LMNAHTT
SCHEMBL24698793 0.89 CASP1 (0.43) CASP1CASP5KMT2ACASP4LMNA
SCHEMBL24698176 0.84 KDM4E (0.44) HTTALDH1A1DRD2DRD4DRD3
SCHEMBL24698194 0.83 LMNA (0.38) CASP1CASP5CASP4LMNAHTT
SCHEMBL24699003 0.82 PRMT6 (0.39) CASP1CASP5LMNAHTTL3MBTL1
SCHEMBL24699383 0.80 LMNA (0.35) CASP1CASP5KMT2ACASP4LMNA
SCHEMBL19623831 0.79 PIK3CA (0.49) LMNAHTTL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL19623475 0.79 ACHE (0.51) KMT2ALMNAHTTL3MBTL1ALDH1A1
SCHEMBL24698819 0.79 PRMT6 (0.44) LMNAHTTL3MBTL1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2050749-B1 PYRIMIDINE DERIVATIVE AS PI3K INHIBITOR AND USE THEREOF CHUGAI PHARMACEUTICAL CO LTD (JP) 2017-11-22 EP disclosed